Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes. | BMC Cancer | 2022 | 35739510 | PubTator, text mining | PubMed |
| Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling. | Nat Neurosci | 2022 | 35739273 | PubTator, text mining | PubMed |
| Decoding lymphomyeloid divergence and immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq. | Cell Discov | 2022 | 35732626 | PubTator, text mining | PubMed |
| TIL classified to memory state are correlated with response to immune checkpoint blockade. | Cell Rep Med | 2022 | 35732152 | PubTator, text mining | PubMed |
| Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease. | Proc Natl Acad Sci U S A | 2022 | 35727985 | PubTator, text mining | PubMed |
| Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection. | Curr Opin Immunol | 2022 | 35724449 | PubTator, text mining | PubMed |
| The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity. | Curr Issues Mol Biol | 2022 | 35723327 | PubTator, text mining | PubMed |
Human Plasma Transcriptome Implicates Dysregulated S100A12 Expression: A Strong, Early-Stage Prognostic Factor in ST-Segment Elevated Myocardial Infarction: Bioinformatics Analysis and Experimental Verification. | Front Cardiovasc Med | 2022 | 35722095 | PubTator, text mining | PubMed |
| Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer. | Front Pharmacol | 2022 | 35721151 | PubTator, text mining | PubMed |
| Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer. | Front Immunol | 2022 | 35720280 | PubTator, text mining | PubMed |
| [Proteolysis and deficiency of α1-proteinase inhibitor in SARS-CoV-2 infection]. | Biomed Khim | 2022 | 35717581 | PubTator, text mining | PubMed |
| Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma. | J Biol Chem | 2022 | 35716777 | PubTator, text mining | PubMed |
| Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for Gene Expression Profiling From Clinical Formalin-Fixed Paraffin-Embedded Tumor Specimens. | Front Cell Dev Biol | 2022 | 35712667 | PubTator, text mining | PubMed |
| Deep Phenotyping of T-Cells Derived From the Aneurysm Wall in a Pediatric Case of Subarachnoid Hemorrhage. | Front Immunol | 2022 | 35711453 | PubTator, text mining | PubMed |
| Granzyme K+ CD8 T cells form a core population in inflamed human tissue. | Sci Transl Med | 2022 | 35704599 | Swiss-Prot, curated | PubMed |
| Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease. | NPJ Parkinsons Dis | 2022 | 35701430 | PubTator, text mining | PubMed |
| Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease. | Front Immunol | 2022 | 35693817 | PubTator, text mining | PubMed |
| The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition. | FEBS Open Bio | 2022 | 35689514 | PubTator, text mining | PubMed |
| Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression. | Blood Cancer Discov | 2022 | 35687817 | PubTator, text mining | PubMed |
| Pan-cancer tumor-infiltrating T cells: A great hallmark in cancer immunology research. | Chin J Cancer Res | 2022 | 35685996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=61